-+ 0.00%
-+ 0.00%
-+ 0.00%

Camp4 Therapeutics shareholders approve amendment to 2024 equity incentive plan at annual meeting

PUBT·06/12/2026 20:12:24
Listen to the news
Camp4 Therapeutics shareholders approve amendment to 2024 equity incentive plan at annual meeting
  • Camp4 Therapeutics held its annual shareholder meeting on June 10, 2026.
  • Shareholders backed an amendment to the 2024 Equity Incentive Plan, updating the evergreen share-count formula to include outstanding pre-funded warrants.
  • Shareholders ratified Ernst & Young as independent auditor for the fiscal year ending Dec. 31, 2026.
  • The board also adopted a 2026 Inducement Plan authorizing up to 500,000 shares for equity awards; no grants were reported.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-042846), on June 12, 2026, and is solely responsible for the information contained therein.